Clear Gene
YC S18San Francisco, US · 4 employees · 2 known investors
Clear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.
AI & Machine LearningBiotechHealthtechMedical DevicesHealthcareDiagnosticsWomen's HealthOncologyUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S18)
BS
Brandon SteelmaninFounder
Investors · 2
Competitors · 2
by search overlapOrigene3 shared keywordsOriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
Neurogene3 shared keywordsNeurogene develops gene therapies for rare neurological diseases, particularly Rett syndrome, using proprietary transgene regulation technology. The company serves patients and families affected by devastating neurological disorders.
Companies competing with Clear Gene for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Clear Gene do?
- Clear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.
- Who founded Clear Gene?
- Clear Gene was founded by Brandon Steelman.
- Who are Clear Gene's investors?
- Clear Gene's investors include Portfolia, Y Combinator.
- Where is Clear Gene headquartered?
- Clear Gene is headquartered in San Francisco, US.